Showing results (171-180 of 946) with videos related to
Sort By:
Pageof 95
Biochemical Pharmacology|May 1, 1991
Acute effects of D-1 and D-2 dopamine receptor agonist and antagonist drugs on basal ganglia [Met5]- and [Leu5]-enkephalin and neurotensin content in the ratM D Taylor, M L de Ceballos, P Jenner, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 1977
Behavioural and biochemical effects of chronic reduction of cerebral noradrenaline receptor stimulationA Dolphin, M Christina, M C Sawaya, et al.Synapse (New York, N.Y.)|July 1, 1996
Intraventricular infusion of basic fibroblast growth factor (bFGF) in the MPTP-treated common marmosetR K Pearce, P Collins, P Jenner, et al.Brain : a Journal of Neurology|September 1, 1976
The involvement of noradrenaline in motor activity as shown by rotational behaviour after unilateral lesions of the locus coeruleusI M Donaldson, A Dolphin, P Jenner, et al.Movement Disorders : Official Journal of the Movement Disorder Society|November 1, 1995
Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus)R K Pearce, M Jackson, L Smith, et al.Life Sciences|July 12, 1982
Increased striatal acetylcholine after 14 months cis-flupenthixol treatment in rats suggests functional supersensitivity of dopamine receptorsK Murugaiah, S Mann, A E Theodorou, et al.Brain Research|February 19, 1996
Dopamine D3 receptors in the basal ganglia of the common marmoset and following MPTP and L-DOPA treatmentM J Hurley, J Jolkkonen, C M Stubbs, et al.British Journal of Pharmacology|January 1, 1978
Functional changes in cerebral 5-hydroxytryptamine metabolism in the mouse induced by anticonvulsant drugsD Chadwick, J W Gorrod, P Jenner, et al.Experimental Brain Research|January 1, 1987
Dopamine and somatostatin modulated adenylate cyclase activity in the rat caudate-putamen following unilateral cortical ablationA Moser, C Reavill, A Liebetrau, et al.Brain : a Journal of Neurology|June 1, 1996
Alterations in peptide levels in Parkinson's disease and incidental Lewy body diseaseA Fernandez, M L de Ceballos, S Rose, et al.Pageof 95